A woman’s insulin levels in midlife are linked to the timing and duration of menopausal hot flashes, night sweats and cold sweats, according to new research from the University of Victoria (UVic). The study found that having higher insulin levels at age 47 predicted younger onsets of hot flashes and night sweats,” says Faria Athar, lead author...
A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking tirzepatide. The findings, published in The Lancet Obstetrics, Gynaecology, & Women’s Health, could expand treatment possibilities for millions of women struggling with obesity and obesity-related diseases after menopause. Menopause can accelerate age-related weight gain and increase the likelihood of...
People with obesity and high blood pressure may face a higher risk of dementia, according to a new study published in The Journal of Clinical Endocrinology & Metabolism. Dementia is a growing global public health challenge, with no cure currently available. People with dementia experience a severe decline in mental abilities, like memory, thinking and reasoning. The most common forms of dementia are Alzheimer’s disease, vascular dementia and mixed dementia. Dementia is a progressive...
Endocrine scientists around the world can now access dkNET, a research portal established by the National Institute of Diabetes and Digestive and Kidney Diseases, which provides endocrine researchers and clinicians with cross-disciplinary access to critical new information. Endocrine News talks with emeritus Endocrine Society member and longtime researcher Robert Margolis, PhD, about how this new...
A rare case study published in JCEM Case Reports details the first known instance of a decades-dormant hormonal disorder, Cyclic Cushing Syndrome (CS), relapsing after a patient contracted COVID-19 and received standard glucocorticoid treatment. The relapse occurred after a remarkable 19-year period of remission, leading researchers to suggest that the stress of the infection and...
The world of endocrinology – and indeed the world – lost a titan at the end of 2025 in Joel Habener, MD, who passed away December 28 at the age of 88. Habener, a professor of medicine at Harvard Medical School and director of the Laboratory of Molecular Endocrinology at Massachusetts General Hospital in Boston,...
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Rezolute Provides Insights from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism and Shares Findings from its Expanded Access Program in Tumor Hyperinsulinism On January 7, Rezolute, Inc., a late-stage rare disease company focused on treating hypoglycemia caused by all forms...
The Endocrine Society is proud of its many distinguished members who lead the global endocrine community by advancing scientific knowledge, providing exemplary care, teaching the next generation of endocrinologists, and improving human health worldwide. For more than 80 years, the Society has recognized the achievements of its members with the annual Laurate Awards. Established in...
People with obesity and high blood pressure may face a higher risk of dementia, according to a new study published in The Journal of Clinical Endocrinology & Metabolism. Dementia is a growing global public health challenge, with no cure currently available. People with dementia experience a severe decline in mental abilities, like memory, thinking and reasoning. The most common forms of dementia are Alzheimer’s disease, vascular dementia and mixed dementia. Dementia is a progressive...
Endocrine scientists around the world can now access dkNET, a research portal established by the National Institute of Diabetes and Digestive and Kidney Diseases, which provides endocrine researchers and clinicians with cross-disciplinary access to critical new information. Endocrine News talks with emeritus Endocrine Society member and longtime researcher Robert Margolis, PhD, about how this new...
The world of endocrinology – and indeed the world – lost a titan at the end of 2025 in Joel Habener, MD, who passed away December 28 at the age of 88. Habener, a professor of medicine at Harvard Medical School and director of the Laboratory of Molecular Endocrinology at Massachusetts General Hospital in Boston,...
